Skip to main content
SpringerLink
Log in

THERAPEUTICS

Transglutaminase 2 inhibitor for coeliac disease

  • In Brief
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • Schuppan, D. et al. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease. N. Engl. J. Med. 385, 35–45 (2021)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Gastroenterology & Hepatology http://www.nature.com/nrgastro/

    Katrina Ray

Authors
  1. Katrina Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katrina Ray.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ray, K. Transglutaminase 2 inhibitor for coeliac disease. Nat Rev Gastroenterol Hepatol 18, 594 (2021). https://doi.org/10.1038/s41575-021-00496-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-021-00496-4

  • Springer Nature Limited

Search

Navigation